Exploring the Relationship Between MDM 4 Gene Polymorphisms (rs1380576 and rs4245739) and Breast Cancer Susceptibility in Bangladesh: A Case–Control Study
Journal of Clinical Laboratory Analysis · 2026-05 · 40 (9)
DOI: 10.1002/jcla.70199 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, online erschienen am 15.03.2026. Verfasst von J M Aousiful Islam und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research Lab, Rufaida BioMeds, Dhaka, Bangladesh. Hauptthemen laut MEDLINE: Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Breast Neoplasms, Proto-Oncogene Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Rufaida BioMeds, BRAC University.
Abstract (Originalsprache)
Background
Breast cancer (BC) is the most common malignancy among Bangladeshi women. MDM4 gene polymorphisms have been implicated in BC susceptibility, but data from South Asian populations remain limited.
Methods
This case–control study included 112 BC patients from a cancer hospital, Dhaka, Bangladesh, and 124 age‐ and sex‐matched healthy controls (HC) from the surrounding areas. Genotyping of MDM4 rs1380576 and rs4245739 polymorphisms was performed using the polymerase chain reaction‐restriction fragment length polymorphism (PCR‐RFLP) method.
Results
Genotype distributions of both polymorphisms conformed to Hardy–Weinberg equilibrium. No association was observed for rs4245739 A>C under any genetic model. In contrast, rs1380576 C>G showed an increased BC risk for CC versus GG (aOR = 3.93; 95% CI = 2.09–7.38; p < 0.001) and for CG + CC versus GG (aOR = 2.04; 95% CI = 1.19–3.50; p = 0.009). The recessive model also indicated elevated risk for CC carriers (aOR = 4.58; 95% CI = 2.46–8.55). A protective effect was observed for the heterozygous genotype in the over‐dominant model (aOR = 0.11; 95% CI = 0.02–0.47; p = 0.003).
Conclusion
The MDM4 rs1380576 C>G polymorphism, particularly the CC genotype, is associated with increased BC risk in Bangladeshi women, whereas rs4245739 A>C shows no association. These findings suggest rs1380576 may serve as a potential genetic marker for BC susceptibility in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Lab, Rufaida BioMeds, Dhaka, Bangladesh.
- Department of Mathematics and Natural Sciences, BRAC University, Dhaka, Bangladesh.
- Betsi Cadwaladr University Health Board, St Asaph, Denbighshire, UK.
- Department of Pharmaceutical Sciences, North South University, Dhaka, Bangladesh.
- School of Pharmacy, BRAC University, Dhaka, Bangladesh.
ORCID-Profile: Md Shaki Mostaid, Md Rabiul Islam, Md Aminul Haque
Förderung
- Rufaida BioMeds
- BRAC University
Zitieren
APA
Islam, J. M. A., Ahamed, S., Islam, S., Hossain, M. M., Hossain, M. S., Mostaid, M. S., Islam, M. R., & Haque, M. A. (2026). Exploring the Relationship Between MDM 4 Gene Polymorphisms (rs1380576 and rs4245739) and Breast Cancer Susceptibility in Bangladesh: A Case–Control Study. Journal of Clinical Laboratory Analysis, 40(9). https://doi.org/10.1002/jcla.70199
Vancouver
Islam JMA, Ahamed S, Islam S, Hossain MM, Hossain MS, Mostaid MS, et al. Exploring the Relationship Between MDM 4 Gene Polymorphisms (rs1380576 and rs4245739) and Breast Cancer Susceptibility in Bangladesh: A Case–Control Study. Journal of Clinical Laboratory Analysis. 2026;40(9). doi:10.1002/jcla.70199
BibTeX
@article{Islam2026,
author = {Islam, J M Aousiful and Ahamed, Sharif and Islam, Shafiqul and Hossain, M Mahboob and Hossain, Md Sadbean and Mostaid, Md Shaki and Islam, Md Rabiul and Haque, Md Aminul},
title = {Exploring the Relationship Between MDM 4 Gene Polymorphisms (rs1380576 and rs4245739) and Breast Cancer Susceptibility in Bangladesh: A Case–Control Study},
journal = {Journal of Clinical Laboratory Analysis},
year = {2026},
volume = {40},
number = {9},
doi = {10.1002/jcla.70199}
}
EUVIMED